Crestline Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-63,125
Closed -$758K 199
2018
Q2
$758K Buy
+63,125
New +$758K 0.08% 212